Gene signature of the post-Chernobyl papillary thyroid cancer

Dose-specific transcriptional responses in thyroid tissue in mice after 131I administration

(2015) Nils Rudqvist et al.   NUCLEAR MEDICINE AND BIOLOGY

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

(2014) Nishant Agrawal et al.   CELL

Iodine-131 dose-dependent gene expression: alterations in both normal and tumour thyroid tissues of post-Chernobyl thyroid cancers

(2013) M Abend et al.   BRITISH JOURNAL OF CANCER

Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers

(2013) Julio C. Ricarte-Filho et al.   JOURNAL OF CLINICAL INVESTIGATION

Comparative Analysis of Transcriptional Gene Regulation Indicates Similar Physiologic Response in Mouse Tissues at Low Absorbed Doses from Intravenously Administered 211At

(2013) B. Langen et al.   JOURNAL OF NUCLEAR MEDICINE

Reconstruction of individual thyroid doses to the Ukrainian subjects enrolled in the Chernobyl Tissue Bank

(2013) I. Likhtarov et al.   RADIATION PROTECTION DOSIMETRY

A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas

(2012) G Dom et al.   BRITISH JOURNAL OF CANCER

Iodine-131 Dose Dependent Gene Expression in Thyroid Cancers and Corresponding Normal Tissues Following the Chernobyl Accident

(2012) Michael Abend et al.   PLoS One

Common genetic variants in pituitary–thyroid axis genes and the risk of differentiated thyroid cancer

(2012) Susana Pastor et al.   Endocrine Connections

Gene Expression Profiles for Radiation-induced Thyroid Cancer

(2011) C. Maenhaut et al.   CLINICAL ONCOLOGY

Clinical Presentation and Clinical Outcomes in Chernobyl-related Paediatric Thyroid Cancers: What Do We Know Now? What Can We Expect in the Future?

(2011) R.M. Tuttle et al.   CLINICAL ONCOLOGY

Strategy to Find Molecular Signatures in a Small Series of Rare Cancers: Validation for Radiation-Induced Breast and Thyroid Tumors

(2011) Nicolas Ugolin et al.   PLoS One

Molecular basis for enhancement of the meiotic DMC1 recombinase by RAD51 associated protein 1 (RAD51AP1)

(2011) Eloïse Dray et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Oncogenic Alterations in Papillary Thyroid Cancers of Young Patients

(2011) Geneviève Sassolas et al.   THYROID

Thyroid cancer incidence in Ukraine: trends with reference to the Chernobyl accident

(2010) M. Fuzik et al.   RADIATION AND ENVIRONMENTAL BIOPHYSICS

PME-1 Protects Extracellular Signal-Regulated Kinase Pathway Activity from Protein Phosphatase 2A-Mediated Inactivation in Human Malignant Glioma

(2009) P. Puustinen et al.   CANCER RESEARCH

Systems Biology Modeling of the Radiation Sensitivity Network: A Biomarker Discovery Platform

(2009) Steven Eschrich et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Copy Number and Gene Expression Alterations in Radiation-Induced Papillary Thyroid Carcinoma from Chernobyl Pediatric Patients

(2009) Leighton Stein et al.   THYROID

Twenty years' experience with post-Chernobyl thyroid cancer

(2008) Dillwyn Williams   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

RET/PTC Rearrangements Preferentially Occurred in Papillary Thyroid Cancer among Atomic Bomb Survivors Exposed to High Radiation Dose

(2008) K. Hamatani et al.   CANCER RESEARCH

ret/PTC Activation Is Not Associated with Individual Radiation Dose Estimates in a Pilot Study of Neoplastic Thyroid Nodules Arising in Russian Children and Adults Exposed to Chernobyl Fallout

(2008) R. Michael Tuttle et al.   THYROID